SRTA

#2886
Strata Critical Medical, Inc. - Class A Common Stock
5.9 7 USD
-0.03%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
5.97
5.97
Intervallo Annuale
3.85
6.50
Variazione giornaliera
-3.24%
Variazione Mensile
+16.83%
Variazione di 6 mesi
+42.14%
Variazione Annuale
+38.19%
Chiusura Precedente
6.1 7
Open
5.9 7
Minimo
5.9 7
Massimo
5.9 7
Volume
62
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Strata Critical Medical, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Strata Critical Medical, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Strata Critical Medical, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Strata Critical Medical, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K

Strata Critical Medical, Inc. current report, Q2 FY2021

Full document

Business Context and Reporting Period

This Form 8-K is filed by Experience Investment Corp. (EIC), not Strata Critical Medical, Inc., for the reporting date of April 7, 2021. EIC is a Special Purpose Acquisition Company (SPAC) listed on the NASDAQ under the symbols EXPCU, EXPC, and EXPCW. The filing announces the scheduling of a special stockholder meeting to approve a business combination with BLADE Urban Air Mobility, Inc. (Blade).

Key Financial Metrics

The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for either EIC or Blade. This report focuses solely on the procedural announcement of the upcoming stockholder vote.

Material Changes and Events

  • Special Meeting Scheduled: EIC has scheduled a special meeting of stockholders for May 5, 2021.
  • Transaction Approval: The meeting will vote on the previously announced business combination with Blade.
  • SEC Filing Status: The Registration Statement on Form S-4 (including the proxy statement/prospectus) was declared effective by the SEC on April 6, 2021.
  • Record Date: Stockholders of record as of March 17, 2021, are eligible to vote.

Guidance, Outlook, and Risks

The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes standard legal disclaimers stating that this communication is not a proxy statement, does not constitute an offer to sell securities, and that no sale of securities will occur in jurisdictions where such an offer would be unlawful. Investors are directed to the definitive proxy statement/prospectus for detailed information regarding risks, contingencies, and the interests of participants in the solicitation.

Investor Verification Checklist

  • Verify the exact date and time of the special stockholder meeting (announced as May 5, 2021).
  • Confirm eligibility to vote based on the record date of March 17, 2021.
  • Review the definitive proxy statement/prospectus (Form S-4) filed with the SEC for detailed transaction terms and risk factors.
  • Check the SEC website (www.sec.gov) or contact EIC directly for copies of the Form S-4 and press release (Exhibit 99.1).
  • Note that the registrant in this filing is Experience Investment Corp., not Strata Critical Medical, Inc.